Table 2 Bleeding events and total outcomes of thoracentesis under clopidogrel versus controls
From: Thoracentesis under clopidogrel is not associated with excessive bleeding events: a cohort study
Clopidogrel treatment (n = 88) | No clopidogrel treatment (n = 169) | RR (95% CI) | |
|---|---|---|---|
Bleeding endpoints | |||
Required packed cells | 2 | 2 | 1.9 (0.3–13.4) |
Hemothorax | 0 | 1 | 0.63 (0.02–15.8) |
> 2 g/dL drop in hemoglobin | 2 | 2 | 1.9 (0.3–13.4) |
Total bleeding events | 4 | 5 | 1.53 (0.4–5.5) |
Other complications, not bleeding related | |||
Pneumothorax | 3 | 2 | 2.9 (0.5–17) |
Re-expansion pulmonary edema | 1 | 0 | 5.7 (0.2–139) |
Total complications | 7 | 7 | 1.9 (0.7–5.3) |